ketorolac has been researched along with nepafenac in 19 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (21.05) | 29.6817 |
| 2010's | 14 (73.68) | 24.3611 |
| 2020's | 1 (5.26) | 2.80 |
| Authors | Studies |
|---|---|
| Acosta, MC; Belmonte, C; Gallar, J; Graff, G; Luna, C; Meseguer, VM; Viana, F | 1 |
| Ernest, P; Gayton, J; Lehmann, R; Raizman, M; Walters, T | 1 |
| Bucci, FA; Waterbury, LD | 3 |
| Awh, CC; Busbee, BG; Cleary, TS; Daniel, P; Heier, JS; Stoller, GL; Waterbury, LD | 1 |
| Bahrani, H; Fox, JE; Warren, KA | 1 |
| Almeida, DR; Bakar, SN; El-Defrawy, SR; Khan, Z; Rahim, K; Urton, T; Xing, L | 1 |
| Chuck, RS; Zhang, C; Zhu, L | 1 |
| Alves, MR; Hida, WT; Motta, AF; Nakano, CT; Nakano, EM; Tzelikis, PF; Vieira, M | 1 |
| Kennedy, J; Singer, DD; Wittpenn, JR | 1 |
| Bom Aggio, F; Bottós, JM; Farah, ME; Rodrigues, EB | 1 |
| Kohnen, T | 1 |
| Bansal, R; Gupta, A; Pandav, SS; Ram, J; Sahu, S | 1 |
| Acar, DE; Acar, M; Acar, U; Erikci, A; Ornek, F; Ozdemir, O; Tanriverdi, C | 1 |
| Chen, Y; Wang, E; Xia, S; Zhao, X | 1 |
| Hernández-Camarena, JC; López-Jaime, GR; Nava-García, JA; Rodríguez-García, A | 1 |
| Holland, E; Hovanesian, J | 1 |
| Ding, K; Heath, M; McDonald, MC; Murphy, DA; Riaz, KM; Shah, S; Shah, SV | 1 |
2 review(s) available for ketorolac and nepafenac
| Article | Year |
|---|---|
Nonsteroidal Anti-Inflammatory Drugs in the Treatment of Retinal Diseases.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Benzeneacetamides; Benzophenones; Bromobenzenes; Diclofenac; Humans; Ketorolac; Phenylacetates; Retinal Diseases | 2016 |
Comparison of the efficacy and patients' tolerability of Nepafenac and Ketorolac in the treatment of ocular inflammation following cataract surgery: A meta-analysis of randomized controlled trials.
Topics: Anterior Chamber; Anti-Inflammatory Agents, Non-Steroidal; Benzeneacetamides; Cataract Extraction; Humans; Inflammation; Ketorolac; Phenylacetates; Postoperative Complications; Randomized Controlled Trials as Topic; Visual Acuity | 2017 |
10 trial(s) available for ketorolac and nepafenac
| Article | Year |
|---|---|
In vivo pharmacokinetics and in vitro pharmacodynamics of nepafenac, amfenac, ketorolac, and bromfenac.
Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Aqueous Humor; Area Under Curve; Benzeneacetamides; Benzophenones; Biological Availability; Bromobenzenes; Cataract Extraction; Chromatography, High Pressure Liquid; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase Inhibitors; Dinoprostone; Double-Blind Method; Female; Humans; Ketorolac; Male; Middle Aged; Phenylacetates | 2007 |
Vitreous nonsteroidal antiinflammatory drug concentrations and prostaglandin E2 levels in vitrectomy patients treated with ketorolac 0.4%, bromfenac 0.09%, and nepafenac 0.1%.
Topics: Administration, Topical; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Benzeneacetamides; Benzophenones; Biological Availability; Bromobenzenes; Chromatography, High Pressure Liquid; Dinoprostone; Female; Humans; Ketorolac; Male; Mass Spectrometry; Middle Aged; Ophthalmic Solutions; Phenylacetates; Retinal Diseases; Tissue Distribution; Vitrectomy; Vitreous Body | 2009 |
NSAIDs in combination therapy for the treatment of chronic pseudophakic cystoid macular edema.
Topics: Aged; Aged, 80 and over; Angiogenesis Inhibitors; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Benzeneacetamides; Benzophenones; Bevacizumab; Bromobenzenes; Diclofenac; Drug Therapy, Combination; Female; Fluorescein Angiography; Glucocorticoids; Humans; Injections; Ketorolac; Macular Edema; Male; Middle Aged; Phenylacetates; Pseudophakia; Retina; Single-Blind Method; Treatment Outcome; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A; Visual Acuity; Vitreous Body | 2010 |
A randomized comparison of to-aqueous penetration of ketorolac 0.45%, bromfenac 0.09% and nepafenac 0.1% in cataract patients undergoing phacoemulsification.
Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Benzeneacetamides; Benzophenones; Bromobenzenes; Cataract; Double-Blind Method; Female; Humans; Ketorolac; Male; Middle Aged; Phenylacetates | 2011 |
Prostaglandin E2 inhibition of ketorolac 0.45%, bromfenac 0.09%, and nepafenac 0.1% in patients undergoing phacoemulsification.
Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Benzeneacetamides; Benzophenones; Bromobenzenes; Dinoprostone; Double-Blind Method; Female; Humans; Ketorolac; Male; Middle Aged; Ophthalmic Solutions; Phacoemulsification; Phenylacetates | 2011 |
Prophylactic nepafenac and ketorolac versus placebo in preventing postoperative macular edema after uneventful phacoemulsification.
Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Benzeneacetamides; Double-Blind Method; Female; Health Status; Humans; Ketorolac; Macular Edema; Male; Middle Aged; Ophthalmic Solutions; Phacoemulsification; Phenylacetates; Postoperative Complications; Prospective Studies; Quality of Life; Surveys and Questionnaires; Tomography, Optical Coherence; Treatment Outcome | 2012 |
Comparison of ketorolac 0.4% and nepafenac 0.1% for the prevention of cystoid macular oedema after phacoemulsification: prospective placebo-controlled randomised study.
Topics: Administration, Topical; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Benzeneacetamides; Female; Humans; Ketorolac; Lens Implantation, Intraocular; Macular Edema; Male; Middle Aged; Ophthalmic Solutions; Phacoemulsification; Phenylacetates; Postoperative Complications; Prospective Studies; Refraction, Ocular; Retina; Tomography, Optical Coherence; Visual Acuity | 2015 |
Topical NSAIDs effect on corneal sensitivity.
Topics: Administration, Topical; Adult; Analgesia; Anesthetics, Local; Anti-Inflammatory Agents, Non-Steroidal; Benzeneacetamides; Benzophenones; Bromobenzenes; Cornea; Diclofenac; Female; Humans; Ketorolac; Male; Ophthalmic Solutions; Phenylacetates; Sensation | 2015 |
Effect of topical ketorolac 0.4%, nepafenac 0.1%, and bromfenac 0.09% on postoperative inflammation using laser flare photometry in patients having phacoemulsification.
Topics: Administration, Topical; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Benzeneacetamides; Benzophenones; Bromobenzenes; Endophthalmitis; Female; Humans; Intraocular Pressure; Ketorolac; Lens Implantation, Intraocular; Male; Middle Aged; Ophthalmic Solutions; Phacoemulsification; Phenylacetates; Photometry; Postoperative Complications; Prospective Studies; Visual Acuity | 2015 |
Tolerability and toxicity of topically applied nepafenac 0.3% compared with generic ketorolac 0.5.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Benzeneacetamides; Drug Tolerance; Female; Follow-Up Studies; Humans; Ketorolac; Male; Ophthalmic Solutions; Phacoemulsification; Phenylacetates; Postoperative Complications; Prospective Studies; Quality of Life; Treatment Outcome; Visual Acuity | 2019 |
7 other study(ies) available for ketorolac and nepafenac
| Article | Year |
|---|---|
Comparative effects of the nonsteroidal anti-inflammatory drug nepafenac on corneal sensory nerve fibers responding to chemical irritation.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Benzeneacetamides; Carbon Dioxide; Cats; Cells, Cultured; Cornea; Diclofenac; Female; Ketorolac; Male; Nociceptors; Patch-Clamp Techniques; Phenylacetates; Presynaptic Terminals; Sodium Channels; Trigeminal Ganglion | 2007 |
Re: Pharmacokinetics and pharmacodynamics of nepafenac, amfenac, ketorolac, and bromfenac.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aqueous Humor; Area Under Curve; Benzeneacetamides; Benzophenones; Biological Availability; Bromobenzenes; Cataract Extraction; Chromatography, High Pressure Liquid; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase Inhibitors; Dinoprostone; Humans; Ketorolac; Phenylacetates | 2008 |
Topical steroid and non-steroidal anti-inflammatory drugs inhibit inflammatory cytokine expression on the ocular surface in the botulinum toxin B-induced murine dry eye model.
Topics: Administration, Topical; Animals; Anti-Inflammatory Agents, Non-Steroidal; Benzeneacetamides; Botulinum Toxins; Botulinum Toxins, Type A; Conjunctiva; Cornea; Disease Models, Animal; Dry Eye Syndromes; Female; Fluorescein; Fluorometholone; Glucocorticoids; Interleukin-1beta; Ketorolac; Lacrimal Apparatus; Mice; Mice, Inbred CBA; Ophthalmic Solutions; Phenylacetates; Tears; Tumor Necrosis Factor-alpha | 2012 |
Treating inflammation after lens surgery.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Benzeneacetamides; Benzophenones; Bromobenzenes; Endophthalmitis; Humans; Ketorolac; Phacoemulsification; Phenylacetates; Postoperative Complications | 2015 |
Prostaglandin E
Topics: Administration, Ophthalmic; Animals; Anti-Inflammatory Agents, Non-Steroidal; Aqueous Humor; Benzeneacetamides; Dinoprostone; Enzyme-Linked Immunosorbent Assay; Ketorolac; Ophthalmic Solutions; Phenylacetates; Rabbits; Vitreous Body | 2017 |
Effect of Topical Nonsteroidal Anti-inflammatory Drugs on Pupillary Size During Uncomplicated Cataract Surgery.
Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Benzeneacetamides; Double-Blind Method; Female; Flurbiprofen; Follow-Up Studies; Humans; Intraoperative Period; Ketorolac; Male; Middle Aged; Ophthalmic Solutions; Phacoemulsification; Phenylacetates; Postoperative Complications; Prospective Studies; Treatment Outcome | 2017 |
Fill levels, cost comparisons, and expulsion force requirements of commonly used topical ophthalmic nonsteroidal anti-inflammatory drugs.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Costs and Cost Analysis; Diclofenac; Humans; Ketorolac; Ophthalmic Solutions; Prospective Studies | 2023 |